Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Price:
5.4 USD
1.89%
Market Closed
Updated:
Jun 11, 2024
Aurinia Pharmaceuticals Inc
Total Current Liabilities
|
Aurinia Pharmaceuticals Inc
Total Current Liabilities Peer Comparison
Comparables:
ZYME
TH
RPTX
FUSN
EDT
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Current Liabilities
$71.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
61%
|
CAGR 10-Years
32%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Current Liabilities
$55.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
Total Current Liabilities
$50.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
28%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Current Liabilities
$39.1m
|
CAGR 3-Years
53%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Current Liabilities
$16.2m
|
CAGR 3-Years
11%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Spectral Medical Inc
TSX:EDT
|
Total Current Liabilities
CA$10.8m
|
CAGR 3-Years
55%
|
CAGR 5-Years
66%
|
CAGR 10-Years
13%
|
See Also
What is Aurinia Pharmaceuticals Inc's Total Current Liabilities?
Total Current Liabilities
71.1m
USD
71.1m
USD
Based on the financial report for Mar 31, 2024, Aurinia Pharmaceuticals Inc's Total Current Liabilities amounts to 71.1m USD.
What is Aurinia Pharmaceuticals Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
32%
32%
Over the last year, the Total Current Liabilities growth was 69%. The average annual Total Current Liabilities growth rates for Aurinia Pharmaceuticals Inc have been 50% over the past three years , 61% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
